Position in PFE
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$480,155
-$35,843 QoQ
Shares Held
19,940
+8.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#1,786
of 2,821 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 94%
Shared 1%
None 5%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROGCO, LP holds $7,250,964 across 7 Drug Manufacturers - General names. PFE ranks #5 (6.6% of the industry book) .
All Filings in PFE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $480,155 | 19,940 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $515,998 | 18,376 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $454,449 | 18,251 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $468,679 | 18,394 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $480,315 | 19,815 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $488,453 | 19,276 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $440,079 | 16,588 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $544,911 | 18,829 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $553,836 | 19,794 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $557,331 | 20,084 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $635,481 | 22,073 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $733,156 | 22,103 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||